A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies
Xin Li, D. Thirumalai

TL;DR
This paper presents a mathematical model that explains intratumor heterogeneity in breast cancer, accurately predicts experimental outcomes, and suggests strategies to optimize therapy by manipulating treatment protocols and tumor cell plasticity.
Contribution
The study introduces a novel mathematical model that quantitatively matches experimental data on breast cancer heterogeneity and predicts how treatment timing and cell plasticity affect therapy outcomes.
Findings
Model accurately predicts cell fraction evolution.
Colony size predictions match experimental data.
Treatment protocol adjustments can improve efficacy.
Abstract
Inevitably, almost all cancer patients develop resistance to targeted therapy. Intratumor heterogeneity (ITH) is a major cause of drug resistance. Mathematical models that explain experiments quantitatively is useful in understanding the origin of ITH, which then could be used to explore scenarios for efficacious therapy. Here, we develop a mathematical model to investigate ITH in breast cancer by exploiting the observation that HER2+ and HER2- cells could divide symmetrically or asymmetrically. Our predictions for the evolution of cell fractions are in quantitative agreement with single-cell experiments. Remarkably, the colony size of HER2+ cells emerging from a single HER2- cell (or vice versa), which occurs in about four cell doublings, agrees perfectly with experimental results, without tweaking any parameter in the model. The theory quantitatively explains experimental data on the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMathematical Biology Tumor Growth · Monoclonal and Polyclonal Antibodies Research · Cancer Cells and Metastasis
